Provided by Tiger Trade Technology Pte. Ltd.

BIODLINK-B

3.690
-0.065-1.73%
Volume:199.60K
Turnover:734.53K
Market Cap:2.85B
PE:-26.66
High:3.780
Open:3.780
Low:3.650
Close:3.755
52wk High:5.870
52wk Low:1.700
Shares:773.00M
HK Float Shares:772.79M
Volume Ratio:0.59
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.138
ROE:-24.21%
ROA:-6.74%
PB:3.96
PE(LYR):-26.66
PS:4.83

Loading ...

TOT Biopharm proposes Deloitte as new auditor as PwC retires

Reuters
·
Jun 04

BioDlink Monthly Return: Issued Shares Steady at 772.79 Million; Public Float Compliant

Bulletin Express
·
Jun 03

BioDlink International Says No Undisclosed Matters That Would Warrant Unusual Movement in Stock Price

MT Newswires Live
·
Jun 03

BIODLINK-B Issues Voluntary Statement to Reaffirm Strong Fundamentals and Outline Growth Trajectory

Stock News
·
Jun 02

BioDlink Cites No Inside Information After Unusual Trading; Advances Post-Merger Integration and Three-Year CDMO Agreement with WuXi XDC

Bulletin Express
·
Jun 02

BIODLINK Convenes 11 June 2026 EGM to Approve CDMO Master Services Agreement with WuXi XDC

Bulletin Express
·
May 26

BioDlink shareholders vote June 11 on WuXi XDC CDMO services pact with RMB 424.8 million 2028 cap

Reuters
·
May 26

BioDlink Reports No Share Capital Changes in April; 7.61 Million Pre-IPO Options Cancelled

Bulletin Express
·
May 07

BIODLINK-B Shares Surge Over 9% Following Appointment of WUXI XDC CEO to Key Roles

Stock News
·
Apr 29

BRIEF-Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson

Reuters
·
Apr 28

BioDlink Announces Comprehensive Board Reshuffle Following WuXi XDC Take-Over

Bulletin Express
·
Apr 28

BIODLINK-B (01875) Appoints Dr. Li Jincai as Executive Director and Board Chairman

Stock News
·
Apr 28

Biodlink International Co Ltd - Mr. Shan Fu Resigns as Executive Director and Chairperson of Board

THOMSON REUTERS
·
Apr 28

Biodlink International Co Ltd - Appoints DR. Jincai Li as Executive Director and Chairperson of Board

THOMSON REUTERS
·
Apr 28

BIODLINK-B 2025年业绩:营收7.48亿元同比下降32%,CDMO业务稳健增长,拟引入战略并购

Bulletin Express
·
Apr 28

TOT BIOPHARM publishes 2025 annual report

Reuters
·
Apr 28

BioDlink Keeps Share Capital Steady at 772.79 Million; Confirms Public Float Compliance in March 2026

Bulletin Express
·
Apr 09